Buy Recommendation Issued On AVY By UBS
UBS analyst issues BUY recommendation for AVY on February 5, 2026 12:27PM ET. The previous analyst recommendation was Buy.AVY was trading at $193.13 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for AVY on February 5, 2026 12:27PM ET. The previous analyst recommendation was Buy.AVY was trading at $193.13 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for BG on February 5, 2026 12:26PM ET. The previous analyst recommendation was Buy.BG was trading at $117.23 at issue of the analyst recommendation.The overall...
UBS analyst issues NEUTRAL recommendation for CBT on February 5, 2026 12:27PM ET. The previous analyst recommendation was Neutral.CBT was trading at $78.73 at issue of the analyst recommendation.The overall...
UBS analyst issues NEUTRAL recommendation for EVR on February 5, 2026 12:28PM ET. The previous analyst recommendation was Neutral.EVR was trading at $356.36 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for FOXA on February 5, 2026 12:28PM ET. The previous analyst recommendation was Buy.FOXA was trading at $67.73 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues MARKET PERFORM recommendation for YUM on February 5, 2026 12:30PM ET. The previous analyst recommendation was Market Perform.YUM was trading at $159.57 at issue of the...
BMO Capital analyst issues OUTPERFORM recommendation for WFRD on February 5, 2026 12:29PM ET. The previous analyst recommendation was Outperform.WFRD was trading at $99.97 at issue of the analyst recommendation.The...
BMO Capital analyst issues MARKET PERFORM recommendation for MC on February 5, 2026 12:27PM ET. The previous analyst recommendation was Market Perform.MC was trading at $70.89 at issue of the...
Morgan Stanley analyst issues OVERWEIGHT recommendation for CME on February 5, 2026 12:27PM ET. The previous analyst recommendation was Overweight.CME was trading at $294.62 at issue of the analyst recommendation.The...
UBS analyst issues NEUTRAL recommendation for WFRD on February 5, 2026 12:35PM ET. The previous analyst recommendation was Neutral.WFRD was trading at $99.97 at issue of the analyst recommendation.The overall...